Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword

Toll-like receptors (TLRs) are a family of transmembrane receptors that recognize various pathogen- and damage-associated molecular pattern molecules playing an important role in inflammation by activating NF-кB. TLRs, mainly expressed by innate immune cells, are involved in inducing and regulating...

Full description

Saved in:
Bibliographic Details
Published inImmunobiology (1979) Vol. 222; no. 1; pp. 89 - 100
Main Authors Dajon, Marion, Iribarren, Kristina, Cremer, Isabelle
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier GmbH 01.01.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Toll-like receptors (TLRs) are a family of transmembrane receptors that recognize various pathogen- and damage-associated molecular pattern molecules playing an important role in inflammation by activating NF-кB. TLRs, mainly expressed by innate immune cells, are involved in inducing and regulating adaptive immune responses. However, the expression of TLRs has also been observed in many tumors, and their stimulation results in tumor progression or regression, depending on the TLR and tumor type. Here we review the role of TLRs in conferring anti- or pro-tumoral effects. The anti-tumoral effects can result from direct induction of tumor cell death and/or activation of efficient anti-tumoral immune responses, and the pro-tumoral effects may be due to inducing tumor cell survival and proliferation or by acting on suppressive or inflammatory immune cells in the tumor microenvironment.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0171-2985
1878-3279
DOI:10.1016/j.imbio.2016.06.009